Liang Wannian: raising the technical value of medical service reasonably

[expert opinion of chinapharma.com] on January 9, the national health and Family Planning Commission held a regular press conference Some reporters put forward that "in view of the problem of inflated drug prices, we should establish a pharmacoeconomic evaluation system as soon as possible What is the current situation of this system?" Liang Wannian, the full-time deputy director of the medical reform office of the State Council and the director of the Department of physical reform of the state health and Family Planning Commission, gave a detailed answer Liang Wannian introduces that the reform made by the health and Family Planning Commission is mainly aimed at the virtual high of drug price and reducing the virtual high of drug price, which is one of the very important measures and goals of the health and Family Planning Commission At present, there is still a part of the drugs used in the domestic and clinical practice with high prices The reform of the public hospitals has been carried out in an all-round way, and a new mechanism for the reform and operation of the public hospitals has been established The main entry point is to squeeze out the water with high prices from the circulation of drugs, to reasonably improve the technical value of medical services after squeezing out the water space, and to carry out the cage for bird exchange Therefore, there must be a part of drug prices that are falsely high, and there are many reasons for the falsely high prices However, there are too many links in the circulation field In addition, some situations such as ticket passing, money laundering and so on have further raised the falsely high prices, which is the focus of the rectification He pointed out that how to ensure the real guarantee of drugs is safe and effective, reliable quality and reasonable price, which is an important principle for the clinical use of drugs From the international experience, the core function of drugs is to ensure safety and effectiveness On this basis, it is necessary to consider its economic benefits, which is a common international practice In the past, China has also adopted these methods in drug selection, but it needs to be further strengthened in terms of system and promotion Now, at the national level, it is also speeding up how to evaluate the consistency of quality and efficacy of current marketed drugs, such as generic drugs In addition, on the basis of meeting the requirements of safety and effectiveness, whose economy and efficiency should be done by economic methods, we are speeding up the formulation of relevant policies in this area to promote this work.